FR940302-2-00060 FR940302-2-00043 Food and Drug Administration [Docket No. 94N&hyph;0044] Riker Laboratories, Inc., et al.; Withdrawal of Approval of 91 New Drug Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of 91 new drug applications (NDA's). The holders of the NDA's notified the agency in writing that the drug products were no longer being marketed under the NDA's and requested that the approval of the applications be withdrawn. EFFECTIVE DATE: April 1, 1994. FOR FURTHER INFORMATION CONTACT: Nancy Maizel, Center for Drug Evaluation and Research (HFD&hyph;53), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4320. SUPPLEMENTARY INFORMATION: The holders of the NDA's listed in the table below have informed FDA that these drug products are no longer being marketed under the NDA's and have requested that FDA withdraw approval of the applications. The applicants have also, by request, waived their opportunity for a hearing.
